ApprovalTrail

Approval · Notice of Compliance 7992 · 2006

VISIPAQUE: Notice of Compliance 7992

Issued May 30, 2006

A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.

Notice number
7992
Date
May 30, 2006
Company
Ge Healthcare Canada IncMississauga, Ontario, Canada
Product type
Nonprescription Pharmaceutical
Submission
New Drug Submission (NDS)
Submission class
Admin
Reason
Manufacturer name change
Therapeutic class
Non-ionic radiographic contrast medium

Products in this notice

BrandDINStatus today
VISIPAQUE02145766Marketed
VISIPAQUE02145774Marketed

Medicinal ingredients